Concepedia

Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries

Tereza Hrnčiarová, Jiří Drahota, Tim Spelman, Jan Hillert, Jan Lycke, Eva Havrdová, Eva Recmanová, Jana Adámková, Jan Mareš, Jana Libertínová,

Multiple Sclerosis and Related Disorders · 2023 · 19 citations · 11 references

DOI

Concepts

References

11

Rating neurologic impairment in multiple sclerosis

John F. Kurtzke · Neurology · 1983 · 14.9K citations

, , +14

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

J William L Brown, Alasdair Coles, Dana Horáková et al. · JAMA · 2019 · 547 citations · Full text

, , +14

Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study

Anna He, B. Merkel, J William L Brown et al. · The Lancet Neurology · 2020 · 438 citations · Full text

, , +8

Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial

John H. Noseworthy, Margaret K. Vandervoort, Chin Jung Wong et al. · Neurology · 1990 · 325 citations

, , +14

Defining reliable disability outcomes in multiple sclerosis

Tomáš Kalinčík, Gary Cutter, Tim Spelman et al. · Brain · 2015 · 243 citations · Full text

, , +16